Utility of the PROSTest, a novel blood-based molecular assay, versus PSA for prostate cancer stratification and detection of higher grade disease. Insight into the global mortality trends due to ...
WEST LAFAYETTE, Ind. — The striking similarities between invasive bladder cancer in dogs and humans have fueled research advances for more than three decades. Most of that work has looked at separate ...
Neoadjuvant pembrolizumab (3 doses) in stage I–III disease yielded a 71% pCR rate and only one melanoma-specific survival event at 3 years post-resection. Experts discuss the SWOG S1512 trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results